Amber Doty

Amber Doty is a seasoned pharmaceutical development professional currently serving as the Senior Director of Pharmaceutical Development Project Leadership & Operations at MindMed since August 2021. Prior to this, Amber held the position of Director of Pharmaceutical Development at Satsuma Pharmaceuticals, Inc., where responsibilities included managing CROs for analytical testing of a dry powder drug-device combination product. Amber's previous experience at AstraZeneca involved leading teams in product development and authoring regulatory documents. Earlier roles at GlaxoSmithKline included extensive analytical testing and technical report writing focused on inhaled dry powder formulations. Amber began a career in the pharmaceutical industry at Talecris Biotherapeutics, Inc. as an Associate Scientist. A Bachelor of Science degree in Chemistry was earned from UNC Greensboro in 2006.